Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 23 of 31

COMPLETED NA

Treatment Resistant Depression (Pilot)

NCT01179009

COMPLETED

Tracking Neurodegeneration in Early Wolfram Syndrome

NCT02455414

COMPLETED NA

Implementation of Evidence-based Treatments for On-campus Eating Disorders

NCT02079142

TERMINATED Phase 1

Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors

NCT01479023

COMPLETED NA

Peri-Operative Steroid Management in Patients

NCT02084134

COMPLETED NA

High Fructose Corn Syrup

NCT02018237

COMPLETED Phase 3

Cognitive Training for Firefighters With Tinnitus

NCT01458821

TERMINATED NA

Metabolic Effects of Hydroxychloroquine

NCT02026232

TERMINATED NA

Early Prevention of Preeclampsia Study

NCT01547390

COMPLETED

Sodium Management in Acute Neurological Injury

NCT01558843

COMPLETED

Urine Proteome of Surgical Patients and Healthy Volunteers

NCT01538823

COMPLETED

Biomarker Correlates of Radiologic Imaging

NCT01538810

COMPLETED Phase 4

The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria

NCT01551186

COMPLETED Phase 1

Dietary Nitrate for Heart Failure

NCT01682356

COMPLETED NA

Depression Outpatient Cardiology Screening Study

NCT01552889

COMPLETED

Physical Activity for Campus Employees

NCT01617499

COMPLETED NA

Calorie Restriction, Protein Supplementation and Metabolic Health

NCT01538836

COMPLETED Phase 2

Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine

NCT01550796

TERMINATED Phase 2

Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency

NCT01379469

COMPLETED Phase 2

A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery

NCT02071251

COMPLETED Phase 2

Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis

NCT01486758

TERMINATED NA

The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead

NCT01259024

COMPLETED Phase 1

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

NCT01339442

COMPLETED

CD36 and Human Fat Taste Perception

NCT02699567

COMPLETED Phase 1

Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging

NCT01693874

COMPLETED

PET Imaging in Patients at Risk for Acute Lung Injury

NCT01486342

COMPLETED

Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People

NCT02011581

COMPLETED

Resect and Discard Approach to Diminutive Colonic Polyps

NCT01877525

TERMINATED Phase 2

Prevention of Post-operative Pneumonia (POPP)

NCT01446874

COMPLETED NA

The Skin Prep Study

NCT01472549

COMPLETED

Role of Dopamine Receptors in Primary Focal Dystonias

NCT01373840

TERMINATED Phase 1

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

NCT01695733

TERMINATED Phase 2

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

NCT01368263

TERMINATED NA

The Role Of Empiric Dilation In Patients With Dysphagia With Normal Endoscopy

NCT01444066

COMPLETED Phase 1

The Effects of Bethanechol on Glucose Homeostasis

NCT01434901

COMPLETED NA

Cervical Lidocaine for Intrauterine Device Insertion Pain

NCT01411995

COMPLETED Phase 2

Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)

NCT01405768

COMPLETED Early Phase 1

Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging

NCT01174056

COMPLETED NA

Healthy Bodies, Healthy Kids

NCT01222494

COMPLETED Early Phase 1

Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

NCT01331590

TERMINATED

Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus

NCT01385540

TERMINATED Phase 1

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

NCT02317302

COMPLETED NA

Fish Oil and Muscle Function

NCT01308957

COMPLETED

Cognitive Speed as an Objective Measure of Tinnitus

NCT01395368

COMPLETED Phase 2

Medtronic Reveal XT Study

NCT01526343

COMPLETED Phase 2

Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents

NCT01246076

COMPLETED

Neural Activation and Connectivity in Response to Exercise and Cognitive Training

NCT01603771

COMPLETED NA

Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study

NCT01469741

COMPLETED

Single Balloon Enterosocpy Obscure Gastrointestinal Bleeding Bleed

NCT01625585

COMPLETED

Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh

NCT01355939

← Previous Page 23 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.